The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 1117-1130

  Srivastava, Raghvendra M ^a   Varalakshmi, Chavvakula ^a   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CD86 ANTIGEN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; ISCHEMIA RESPONSIVE PROTEIN 94; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR PROTEIN 2; NITRIC OXIDE; P13K PROTEIN; PHOSPHATASE; PROTEIN KINASE C; RECEPTOR PROTEIN; T6 ANTIGEN; UNCLASSIFIED DRUG; CD1 ANTIGEN; HEAT SHOCK PROTEIN 110; HSPA4 PROTEIN, RAT; IMMUNOGLOBULIN RECEPTOR; LECTIN; LIGAND; NATURAL KILLER CELL ACTIVATING RECEPTORS; NKR P2 PROTEIN, RAT; NKR-P2 PROTEIN, RAT;

ADAPTIVE IMMUNITY; AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RAT; T LYMPHOCYTE; TH1 CELL; TUMOR CELL; TUMOR IMMUNITY; UPREGULATION; ANIMAL; GENETICS; IMMUNOLOGY; MALE; METABOLISM; NATURAL KILLER CELL; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD86; APOPTOSIS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HSP110 HEAT-SHOCK PROTEINS; INTERLEUKIN-12; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; UP-REGULATION;

EID: 40449117427     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.1117     Document Type: Article

References (85)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
3. Nouri-Shirazi, M., J. Banchereau, D. Bell, S. Burkeholder, E. T. Kraus, J. Davoust, and K. A. Palucka. 2000. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. 165: 3797-3803.
4. high macrophages is associated with skin tumour regression. Int. J. Cancer 106: 736-744.
5. van den Broeke, L. T., E. Daschbach, E. K. Thomas, G. Andringa, and J. A. Berzofsky. 2003. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J. Immunol. 171: 5842-5852.
6. Furumoto, K., L. Soares, E. G. Engleman, and M. Merad. 2004. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J. Clin. Invest. 113: 774-783.
7. Janjic, B. M., G. Lu, A. Pimenov, T. L. Whiteside, W. J. Storkus, and N. L. Vujanovic. 2002. Innate direct anticancer effector function of human immature dendritic cells: I, involvement of an apoptosis-inducing pathway. J. Immunol. 168: 1823-1830.
8. Manna, P. P., and T. Mohanakumar. 2002. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro. J. Leukocyte Biol. 72: 312-320.
9. Chapoval, A. I., K. Tamada, and L. Chen. 2000. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95: 2346-2351.
10. 2, Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 168: 1831-1839.
11. Trinite, B., C. Voisine, H. Yagita, and R. Josien. 2000. A subset of cytolytic dendritic cells in rat. J. Immunol. 165: 4202-4208.
12. Alli, R., B. Savithri, S. Das, C. Varalakshmi, N. Rangaraj, and A. Khar. 2004. Involvement of NKR-P2/NKG2D in DC-mediated killing of tumor targets: indicative of a common, innate, target-recognition paradigm? Eur. J. Immunol. 34: 1119-1126.
13. Srivastava, R. M., C. Varalakshmi, and A. Khar. 2007. Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response. Int. Immunol. 19: 591-607.
14. Nicolas, A., D. Cathelin, N. Larmonier, J. Fraszczak, P. E. Puig, A. Bouchot, A. Bateman, E. Solary, and B. Bonnotte. 2007. Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanism. J. Immunol. 179: 812-818.
15. Berg, S. F., E. Dissen, I. H. Westgaard, and S. Fossum. 1998. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. Int. Immunol. 10: 379-385.
16. + macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype. Blood 107: 2004-2012.
17. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
18. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
19. Guilloton, F., A. de Thonel, C. Jean, C. Demur, V. Mansat-De Mas, G. Laurent, and A. Quillet-Mary. 2005. TNFα stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells. Leukemia 19: 2206-2214.
20. Coudert, J. D., and W. Held. 2006. The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 16: 333-343.
21. Mistry, A. R., and C. A. O'Callaghan. 2007. Regulation of ligands for the activating receptor NKG2D. Immunology 121: 439-447.
22. Savithri, B., and A. Khar. 2006. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D. Eur. J. Immunol. 36: 107-117.
23. Radaev, S., M. Kattah, Z. Zou, M. Colonna, and P. D. Sun. 2002. Making sense of the diverse ligand recognition by NKG2D. J. Immunol. 169: 6279-6285.
24. Garrity, D., M. E. Call, J. Feng, and K. W. Wucherpfennig. 2005. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc. Natl. Acad. Sci. USA 102: 7641-7646.
25. Khar, A. 1986. Development and characterization of a rat histiocyte-macrophage tumor line. J. Natl. Cancer Inst. 76: 871-878.
26. Alli, R. S., and A. Khar. 2004. Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function. FEBS Letters 559: 71-76.
27. Yagita, Y., K. Kitagawa, A. Taguchi, T. Ohtsuki, K. Kuwabara, T. Mabuchi, M. Matsumoto, T. Yanagihara, and M. Hori. 1999. Molecular cloning of a novel member of the HSP110 family of genes, ischemia-responsive protein 94 kDa (irp94), expressed in rat brain after transient forebrain ischemia. J. Neurochem. 72: 1544-1551.
28. Yagita, Y., K. Kitagawa, T. Ohtsuki, S. Tanaka, M. Hori, and M. Matsumoto. 2001. Induction of the HSP110/105 family in the rat hippocampus in cerebral ischemia and ischemic tolerance. J. Cereb. Blood Flow Metab. 21: 811-819.
29. Kim, S.W., K. Kwon, K. Shin, S. Kim, and O. Y. Kwon. 2006. Ischemia-responsive protein (irp94) is up-regulated by endoplasmic reticulum stress. J. Exp. Biomed. Sci. 12: 81-89.
30. Theriault, J. R., H. Adachi, and S. K. Calderwood. 2006. Role of scavenger receptors in the binding and internalization of heat shock protein 70. J. Immunol. 177: 8604-8611.
31. Srivastava, P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2: 185-194.
32. Multhoff, G., C. Botzler, M. Wiesnet, E. Muller, T. Meier, W. Wilmanns, and R. D. Issels. 1995. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int. J. Cancer 61: 272-279.
33. Ferrarini, M., S. Heltai, M. R. Zocchi, and C. Rugarli. 1992. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 51: 613-619.
34. Kleinjung, T., O. Arndt, H. J. Feldmann, U. Bockmuhl, M. Gehrmann, T. Zilch, K. Pfister, J. Schonberger, J. Marienhagen, C. Eilles, et al. 2003. Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells. Int. J. Radiat. Oncol. Biol. Phys. 57: 820-826.
35. Multhoff, G. 2006. Heat shock proteins in immunity. Handb. Exp. Pharmacol. 172: 279-304.
36. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Storm, D. R., K. S. Rosenthal, and P. E. Swanson. 1977. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46: 723-763.
38. Geijtenbeek, T. B., S. J. van Vliet, A. Engering, B. A. t' Hart, and Y. van Kooyk. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22: 33-54.
39. Schmitz, M., S. Zhao, Y. Deuse, K. Schakel, R. Wehner, H. Wohner, K. Holig, F. Wienforth, A. Kiessling, M. Bornhauser, et al. 2005. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J. Immunol. 174: 4127-4134.
40. Shi, J., K. Ikeda, N. Fujii, E. Kondo, K. Shinagawa, F. Ishimaru, K. Kaneda, M. Tanimoto, X. Li, and Q. Pu. 2005. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci. 96: 127-133.
41. Galazka, G., A. Jurewicz, W. Orlowski, M. Stasiolek, C. F. Brosnan, C. S. Raine, and K. Selmaj. 2007. EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity. J. Immunol. 179: 4503-4512.
42. Venkataraman, G. M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178: 961-969.
43. Mambula, S. S., and S. K. Calderwood. 2006. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177: 7849-7857.
44. Robert, J., A. Menoret, and N. Cohen. 1999. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. J. Immunol. 163: 4133-4139.
45. Multhoff, G., C. Botzler, L. Jennen, J. Schmidt, J. Ellwart, and R. Issels. 1997. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J. Immunol. 158: 4341-4350.
46. Kotsiopriftis, M., J. E. Tanner, and C. Alfieri. 2005. Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes γδ T-cell proliferation in vitro. J. Virol. 79: 7255-7261.
47. Pfister, G., C. M. Stroh, H. Perschinka, M. Kind, M. Knoflach, P. Hinterdorfer, and G. Wick. 2005. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J. Cell Sci. 118: 1587-1594.
48. Hirsh, M. I., N. Hashiguchi, Y. Chen, L. Yip, and W. G. Junger. 2006. Surface expression of HSP72 by LPS-stimulated neutrophils facilitates γδT cell-mediated killing. Eur. J. Immunol. 36: 712-721.
49. Liu, B., J. Dai, H. Zheng, D. Stoilova, S. Sun, and Z. Li. 2003. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc. Natl. Acad. Sci. USA 100: 15824-15829.
50. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
51. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277: 15028-15034.
52. Becker, T., F. U. Hartl, and F. Wieland. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158: 1277-1285.
53. + T cells and dendritic cells. J. Immunol. 178: 1671-1679.
54. Kettner, S., F. Kalthoff, P. Graf, E. Priller, F. Kricek, I. Lindley, and T. Schweighoffer. 2007. EWI-2/CD316 is an inducible receptor of HSPA8 on human dendritic cells. Mol. Cell. Biol. 27: 7718-7726.
55. Manjili, M. H., J. Park, J. G. Facciponte, and J. R. Subjeck. 2005. HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology 210: 295-303.
56. +) mice. Cancer Sci. 98: 1930-1935.
57. Facciponte, J. G., X. Y. Wang, and J. R. Subjeck. 2007. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Eur. J. Immunol. 37: 2268-2279.
58. Wang, X. Y., J. Facciponte, X. Chen, J. R. Subjeck, and E. A. Repasky. 2007. Scavenger receptor-A negatively regulates antitumor immunity. Cancer Res. 67: 4996-5002.
59. Wang, Y., C. G. Kelly, M. Singh, E. G. McGowan, A. S. Carrara, L. A. Bergmeier, and T. Lehner. 2002. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169: 2422-2429.
60. Wang, Y., T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, and T. Lehner. 2005. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174: 3306-3316.
61. Khar, A., A. L. Kumari, B. V. Pardhasaradhi, C. Varalakshmi, and N. Rangaraj. 2006. Heat stress induced apoptosis in BC-8 cells derived from AK-5 tumor involves downregulation of Bcl-2 and generation of reactive oxygen species. Indian J. Exp. Biol. 44: 802-808.
62. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916.
63. Panjwani, N. N., L. Popova, and P. K. Srivastava. 2002. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168: 2997-3003.
64. Lu, L., C. A. Bonham, F. G. Chambers, S. C. Watkins, R. A. Hoffman, R. L. Simmons, and A. W. Thomson. 1996. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol. 157: 3577-3586.
65. Aiello, S., M. Noris, G. Piccinini, S. Tomasoni, F. Casiraghi, S. Bonazzola, M. Mister, M. H. Sayegh, and G. Remuzzi. 2000. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens. J. Immunol. 164: 4649-4658.
66. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 204: 1441-1451.
67. Farias-Eisner, R., M. P. Sherman, E. Aeberhard, and G. Chaudhuri. 1994. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA 91: 9407-9411.
68. Bhaumik, S., and A. Khar. 1998. Induction of nitric oxide production by the peritoneal macrophages after intraperitoneal or subcutaneous transplantation of AK-5 tumor. Nitric Oxide 2: 467-474.
69. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
70. Shimamura, H., R. Cumberland, K. Hiroishi, S. C. Watkins, M. T. Lotze, and J. Baar. 2002. Murine dendritic cell-induced tumor apoptosis is partially mediated by nitric oxide. J. Immunother. 25: 226-234.
71. Gad, M., M. H. Claesson, and A. E. Pedersen. 2003. Dendritic cells in peripheral tolerance and immunity. APMIS 111: 766-775.
72. Khar, A., and R. Anjum. 2001. Host-tumor interactions during the regression of a rat histiocytoma, AK-5. Immunol. Rev. 184: 244-257.
73. Degli-Esposti, M. A., and M. J. Smyth. 2005. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5: 112-124.
74. Groh, V., Y. Q. Li, D. Cioca, N. N. Hunder, W. Wang, S. R. Riddell, C. Yee, and T. Spies. 2005. Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proc. Natl. Acad. Sci. USA 102: 6461-6466.
75. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12: 1539-1546.
76. Wong, S. H., L. Santambrogio, and J. L. Strominger. 2004. Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins. Proc. Nat. Acad. Sci. USA 101: 17783-17788.
77. Cruz, M. T., C. B. Duarte, M. Goncalo, A. P. Carvalho, and M. C. Lopes. 1999. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells. Am. J. Physiol. 277: C1050-C1057.
78. Flohe, S. B., J. Bruggemann, S. Lendemans, M. Nikulina, G. Meierhoff, S. Flohe, and H. Kolb. 2003. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170: 2340-2348.
79. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
80. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
81. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708.
82. Yoshimura, S., J. Bondeson, B. M. Foxwell, F. M. Brennan, and M. Feldmann. 2001. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules, and cytokines. Int. Immunol. 13: 675-683.
83. Zheng, H., J. Dai, D. Stoilova, and Z. Li. 2001. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol. 167: 6731-6735.
84. Clark, P. R., and A. Menoret. 2001. The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones 6: 121-125.
85. Obeid, M., A. Tesniere, F. Ghiringhelli, G. M. Fimia, L. Apetoh, J. L. Perfettini, M. Castedo, G. Mignot, T. Panaretakis, N. Casares, et al. 2007. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13: 54-61.